Summary

Hemoglobin A1c Testing Devices Market – Scope of Report
TMR’s report on the global hemoglobin A1c testing devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global hemoglobin A1c testing devices market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hemoglobin A1c testing devices market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the hemoglobin A1c testing devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hemoglobin A1c testing devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global hemoglobin A1c testing devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hemoglobin A1c testing devices market.

The report delves into the competitive landscape of the global hemoglobin A1c testing devices market. Key players operating in the global hemoglobin A1c testing devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hemoglobin A1c testing devices market profiled in this report.

Key Questions Answered in Global hemoglobin A1c testing devices Market Report
• What is the sales/revenue generated by hemoglobin A1c testing devices across all regions during the forecast period?
• What are the opportunities in the global hemoglobin A1c testing devices market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Hemoglobin A1c Testing Devices Market – Research Objectives and Research Approach
The comprehensive report on the global hemoglobin A1c testing devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global hemoglobin A1c testing devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hemoglobin A1c testing devices market.

ページTOPに戻る

Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hemoglobin A1c Testing Devices Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, 2020-2034
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. PESTEL Analysis
    5.2. Regulatory Scenario by Region/Country
    5.3. PORTER’s Five Forces Analysis
    5.4. Product/Brand Analysis of Haemoglobin A1c Testing Devices
    5.5. Technological Advancement
    5.6. Incidence and Prevalence Rate of Diabetes
6. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by Technology
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Technology, 2020-2034
        6.3.1. Cation-exchange Chromatography
        6.3.2. Immunoassay
        6.3.3. Boronate Affinity Chromatography
        6.3.4. Others (Enzymatic assay, etc.)
    6.4. Market Attractiveness Analysis, by Technology
7. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by Modality
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Modality, 2020-2034
        7.3.1. Automated
        7.3.2. Semi-automated
    7.4. Market Attractiveness Analysis, by Modality
8. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by End-user, 2020-2034
        8.3.1. Hospitals
        8.3.2. Diagnostic Laboratories
        8.3.3. Ambulatory Surgical Centres
        8.3.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
    8.4. Market Attractiveness Analysis, by End-user
9. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region, 2020-2034
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Hemoglobin A1c Testing Devices Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Technology, 2020-2034
        10.2.1. Cation-exchange Chromatography
        10.2.2. Immunoassay
        10.2.3. Boronate Affinity Chromatography
        10.2.4. Others (Enzymatic assay, etc.)
    10.3. Market Value Forecast, by Modality, 2020-2034
        10.3.1. Automated
        10.3.2. Semi-automated
    10.4. Market Value Forecast, by End-user, 2020-2034
        10.4.1. Hospitals
        10.4.2. Diagnostic Laboratories
        10.4.3. Ambulatory Surgical Centres
        10.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
    10.5. Market Value Forecast, by Country, 2020-2034
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Technology
        10.6.2. By Modality
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Hemoglobin A1c Testing Devices Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Technology, 2020-2034
        11.2.1. Cation-exchange Chromatography
        11.2.2. Immunoassay
        11.2.3. Boronate Affinity Chromatography
        11.2.4. Others (Enzymatic assay, etc.)
    11.3. Market Value Forecast, by Modality, 2020-2034
        11.3.1. Automated
        11.3.2. Semi-automated
    11.4. Market Value Forecast, by End-user, 2020-2034
        11.4.1. Hospitals
        11.4.2. Diagnostic Laboratories
        11.4.3. Ambulatory Surgical Centres
        11.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
    11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
        11.5.1. Germany
        11.5.2. UK
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Technology
        11.6.2. By Modality
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Hemoglobin A1c Testing Devices Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Technology, 2020-2034
        12.2.1. Cation-exchange Chromatography
        12.2.2. Immunoassay
        12.2.3. Boronate Affinity Chromatography
        12.2.4. Others (Enzymatic assay, etc.)
    12.3. Market Value Forecast, by Modality, 2020-2034
        12.3.1. Automated
        12.3.2. Semi-automated
    12.4. Market Value Forecast, by End-user, 2020-2034
        12.4.1. Hospitals
        12.4.2. Diagnostic Laboratories
        12.4.3. Ambulatory Surgical Centres
        12.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
    12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Technology
        12.6.2. By Modality
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Hemoglobin A1c Testing Devices Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Technology, 2020-2034
        13.2.1. Cation-exchange Chromatography
        13.2.2. Immunoassay
        13.2.3. Boronate Affinity Chromatography
        13.2.4. Others (Enzymatic assay, etc.)
    13.3. Market Value Forecast, by Modality, 2020-2034
        13.3.1. Automated
        13.3.2. Semi-automated
    13.4. Market Value Forecast, by End-user, 2020-2034
        13.4.1. Hospitals
        13.4.2. Diagnostic Laboratories
        13.4.3. Ambulatory Surgical Centres
        13.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
    13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Technology
        13.6.2. By Modality
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East & Africa Hemoglobin A1c Testing Devices Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Technology, 2020-2034
        14.2.1. Cation-exchange Chromatography
        14.2.2. Immunoassay
        14.2.3. Boronate Affinity Chromatography
        14.2.4. Others (Enzymatic assay, etc.)
    14.3. Market Value Forecast, by Modality, 2020-2034
        14.3.1. Automated
        14.3.2. Semi-automated
    14.4. Market Value Forecast, by End-user, 2020-2034
        14.4.1. Hospitals
        14.4.2. Diagnostic Laboratories
        14.4.3. Ambulatory Surgical Centres
        14.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
    14.5. Market Value Forecast, by Country/Sub-region, 2020-2034
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Technology
        14.6.2. By Modality
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player - Competition Matrix (By Tier and Size of companies)
    15.2. Market Share Analysis By Company (2023)
    15.3. Company Profiles
        15.3.1. Alere Technologies AS (Abbott)
            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.1.2. Product Portfolio
            15.3.1.3. Financial Overview
            15.3.1.4. SWOT Analysis
            15.3.1.5. Strategic Overview
        15.3.2. GC Medical Science Corp.
            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.2.2. Product Portfolio
            15.3.2.3. Financial Overview
            15.3.2.4. SWOT Analysis
            15.3.2.5. Strategic Overview
        15.3.3. Osang Healthcare Co., Ltd
            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.3.2. Product Portfolio
            15.3.3.3. Financial Overview
            15.3.3.4. SWOT Analysis
            15.3.3.5. Strategic Overview
        15.3.4. EKF Diagnostics Holdings
            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.4.2. Product Portfolio
            15.3.4.3. Financial Overview
            15.3.4.4. SWOT Analysis
            15.3.4.5. Strategic Overview
        15.3.5. Boditech Med Inc.
            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.5.2. Product Portfolio
            15.3.5.3. Financial Overview
            15.3.5.4. SWOT Analysis
            15.3.5.5. Strategic Overview
        15.3.6. Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.6.2. Product Portfolio
            15.3.6.3. Financial Overview
            15.3.6.4. SWOT Analysis
            15.3.6.5. Strategic Overview
        15.3.7. Eurolyser Diagnostica GmbH
            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.7.2. Product Portfolio
            15.3.7.3. Financial Overview
            15.3.7.4. SWOT Analysis
            15.3.7.5. Strategic Overview
        15.3.8. Bayer AG
            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.8.2. Product Portfolio
            15.3.8.3. Financial Overview
            15.3.8.4. SWOT Analysis
            15.3.8.5. Strategic Overview
        15.3.9. Siemens Healthineers
            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.9.2. Product Portfolio
            15.3.9.3. Financial Overview
            15.3.9.4. SWOT Analysis
            15.3.9.5. Strategic Overview
        15.3.10. Other Prominent Players
            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.10.2. Product Portfolio
            15.3.10.3. Financial Overview
            15.3.10.4. SWOT Analysis
            15.3.10.5. Strategic Overview